Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$56,474,678
New position
Shares Held
360,354
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#52
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AGF MANAGEMENT LTD holds $1,321,975,737 across 10 Drug Manufacturers - General names. NVS ranks #4 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
556,470 | $667,446,866 | |
| 2 | JNJ |
Johnson & Johnson
|
1,545,100 | $392,409,044 | |
| 3 | ABBV |
AbbVie Inc.
|
652,937 | $164,305,065 | |
| 4 | NVS |
Novartis AG
This page
|
360,354 | $56,474,678 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
334,104 | $19,251,072 | |
| 6 | PFE |
Pfizer Inc
|
434,814 | $10,470,321 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
43,538 | $5,500,590 | |
| 8 | AMGN |
Amgen Inc
|
9,492 | $3,437,243 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,474,678 | 360,354 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||